Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000066

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President
Period of report
Oct 15, 2018
Accepted (ET)
Oct 19, 2018 · 3:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockOct 15, 2018P2,000$0.0488A26,030,898D
Common StockOct 15, 2018P3,000$0.0495A26,033,898D
Common StockOct 15, 2018P2,000$0.0492A26,035,898D
Common StockOct 15, 2018P3,500$0.0484A26,039,398D
Common StockOct 15, 2018P1,000$0.0484A26,040,398D
Common StockOct 15, 2018P1,000$0.049A26,041,398D
Common StockOct 15, 2018P1,000$0.0487A26,042,398D
Common StockOct 15, 2018P1,000$0.049A26,043,398D
Common StockOct 15, 2018P1,000$0.0458A26,044,398D
Common StockOct 15, 2018P1,000$0.046A26,045,398D
Common StockOct 15, 2018P100$0.0458A26,045,498D
Common StockOct 15, 2018P1,000$0.0458A26,046,498D
Common StockOct 15, 2018P1,000$0.0474A26,047,498D
Common StockOct 15, 2018P1,000$0.0474A26,048,498D
Common StockOct 15, 2018P3,000$0.0474A26,051,498D
Common StockOct 15, 2018P1,000$0.0477A26,052,498D
Common StockOct 15, 2018P1,000$0.0474A26,053,498D
Common StockOct 15, 2018P1,000$0.0474A26,054,498D
Common StockOct 15, 2018P2,000$0.0474A26,056,498D
Common StockOct 15, 2018P3,000$0.0474A26,059,498D
Common StockOct 16, 2018P2,000$0.0442A26,061,498D
Common StockOct 16, 2018P1,000$0.0426A26,062,498D
Common StockOct 16, 2018P1,000$0.0444A26,063,498D
Common StockOct 16, 2018P1,000$0.044A26,064,498D

Table II — derivative securities

No Table II lines on this filing.